Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Top Cited Papers
- 2 January 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 115 (1) , 114-126
- https://doi.org/10.1161/circulationaha.106.179294
Abstract
The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: The ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.Keywords
This publication has 75 references indexed in Scilit:
- Diet and Lifestyle Recommendations Revision 2006Circulation, 2006
- Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril StudyHypertension, 2004
- Challenge of identifying patients with diabetes mellitus who are at low risk for coronary events by use of cardiac stress imagingAmerican Heart Journal, 2004
- Nutrition Principles and Recommendations in DiabetesDiabetes Care, 2004
- Third-Generation β-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP EffluxCirculation, 2003
- Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)Hypertension, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trialThe American Journal of Cardiology, 1995
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987